SRI stock trades at USD 6.72 as Q2 sales rise 15.1 percent

Published on 10/04/2026 at 11:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SRI stock last traded at USD 6.72 on October 2, 2026, while Q2 sales rose 15.1 percent to USD 181.4 million. Management kept its 2026 guidance.

SRI, US86183P1021, Illustration mit AI erstellt.

Stoneridge (ISIN US86183P1021) last traded at USD 6.72 on the NYSE on October 2, 2026, up 0.30 percent from the prior close. The company’s second-quarter 2026 sales rose 15.1 percent year over year to USD 181.4 million, giving the stock a clearer operating growth signal despite continued losses.

Q2 sales grow while margins narrow

According to Stock Titan in its August 5, 2026 filing summary, Stoneridge reported a USD 5.3 million net loss from continuing operations, or USD 0.19 per diluted share, compared with a USD 11.1 million loss, or USD 0.40 per share, in the year-earlier quarter.

The improvement in the bottom line came with a margin trade-off. Gross margin fell to 20.3 percent from 23.1 percent in Q2 2025, while adjusted EBITDA increased to USD 5.5 million from USD 0.8 million, lifting the adjusted EBITDA margin to 3.0 percent from 0.5 percent.

Guidance keeps MirrorEye central

Stoneridge reaffirmed 2026 revenue guidance of USD 645 million to USD 670 million and adjusted EBITDA guidance of USD 20 million to USD 25 million in the same August 5, 2026 filing summary. Electronics revenue rose 12.8 percent to USD 160.9 million, while Stoneridge Brazil revenue increased 37.6 percent to USD 20.5 million.

For investors, the key comparison is growth against profitability. The Q2 sales increase was 15.1 percent, but the 20.3 percent gross margin remained below the 23.1 percent recorded a year earlier. That gap leaves cost control and product mix as important tests for the next report.

Analyst view stays at Hold

As Markets Insider reported on October 1, 2026, Barrington analyst Gary Prestopino maintained a Hold rating on Stoneridge. The same report described the analyst consensus as Hold, leaving the improving revenue trend balanced against the company’s still negative earnings profile.

Stock remains below yearly high

SRI last traded at USD 6.72 on the NYSE on October 2, 2026, with volume of 159,054 shares. The 52-week range was USD 4.60 to USD 9.71, placing the reference price USD 2.99 below the yearly high and USD 2.12 above the low.